UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical infectious diseases, ISSN 1058-4838, 6/2014, Volume 58, Issue 12, pp. 1668 - 1675
ARTICLES AND COMMENTARIES | mortality | methicillin-susceptible Staphylococcus aureus | left-sided endocarditis | vancomycin minimal inhibitory concentration | cloxacillin | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Cardiology. Vascular system | Heart | Endocardial and cardiac valvular diseases | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Staphylococcal infections, streptococcal infections, pneumococcal infections | Biological and medical sciences | Medical sciences | Antibacterial agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Endocarditis, Bacterial - drug therapy | Staphylococcal Infections - drug therapy | Hospital Mortality | Humans | Middle Aged | Male | Survival Rate | Cloxacillin - pharmacology | Microbial Sensitivity Tests | Daptomycin - pharmacology | Vancomycin - pharmacology | Endocarditis, Bacterial - microbiology | Adult | Female | Aged | Anti-Bacterial Agents - pharmacology | Retrospective Studies | Staphylococcal Infections - microbiology | Staphylococcus aureus - drug effects | Usage | Care and treatment | Mortality | Analysis | Endocarditis | Vancomycin | Research | Health aspects | Staphylococcus aureus | Staphylococcus infections | Regression analysis | Antibiotics | Drug resistance | Risk assessment | Index Medicus
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2013, Volume 112, Issue 10, pp. 1646 - 1651
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Heart Valve Diseases - microbiology | Prevalence | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Staphylococcal Infections - complications | Hospital Mortality - trends | Endocarditis - microbiology | Endocarditis - diagnosis | Heart Valve Diseases - complications | Female | Heart Valve Diseases - diagnosis | Endocarditis - complications | Echocardiography | Survival Rate - trends | Risk Assessment | Pericardial Effusion - diagnosis | Risk Factors | Pericardial Effusion - epidemiology | Staphylococcal Infections - diagnosis | Spain - epidemiology | Pericardial Effusion - etiology | Infective endocarditis | Valves | Health aspects | Mortality | Risk factors | Liver diseases | Embolisms | Multivariate analysis | Studies | Confidence intervals | Variables | Hepatitis | Hospitals | Womens health | Human immunodeficiency virus--HIV | Age | Index Medicus | Abridged Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 08/2012, Volume 56, Issue 8, pp. 4511 - 4515
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Cardiology. Vascular system | Heart | Endocardial and cardiac valvular diseases | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Staphylococcal infections, streptococcal infections, pneumococcal infections | Biological and medical sciences | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Endocarditis, Bacterial - drug therapy | Staphylococcal Infections - drug therapy | Fosfomycin - therapeutic use | Fosfomycin - adverse effects | Humans | Methicillin-Resistant Staphylococcus aureus - drug effects | Middle Aged | Male | Drug Synergism | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Fosfomycin - administration & dosage | Female | Aged | Anti-Bacterial Agents - adverse effects | Staphylococcal Infections - microbiology | Daptomycin - adverse effects | Drug Therapy, Combination | Anti-Bacterial Agents - administration & dosage | Daptomycin - administration & dosage | Daptomycin - therapeutic use | Index Medicus | Clinical Therapeutics
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2018, Volume 71, Issue 24, pp. 2731 - 2740
antibiotic prophylaxis | endocarditis | mitral valve prolapse | bicuspid aortic valve | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Aortic Valve - abnormalities | Humans | Middle Aged | Mitral Valve Prolapse - complications | Male | Antibiotic Prophylaxis | Bicuspid Aortic Valve Disease | Endocarditis - microbiology | Endocarditis - prevention & control | Heart Valve Diseases - complications | Adult | Female | Registries | Aged | Heart failure | Prostheses | Mitral valve | Statistical analysis | Risk groups | Heart surgery | Complications | Indication | Embolisms | Mortality | Prophylaxis | Risk | Patients | Heart valves | Microorganisms | Hospitals | Antibiotics | Endocarditis | Aorta | Aortic valve
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2015, Volume 66, Issue 19, pp. 2156 - 2156
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Heart Valve Prosthesis Implantation - statistics & numerical data | Staphylococcal Infections - epidemiology | Risk Assessment | Humans | Streptococcal Infections - epidemiology | Heart Valve Diseases - surgery | Endocarditis - epidemiology
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2013, Volume 57, Issue 5, pp. 2319 - 2325
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Streptococcus bovis - physiology | Species Specificity | Humans | Microbial Sensitivity Tests | Streptococcus mutans - physiology | Gentamicins - pharmacology | Vancomycin - pharmacology | Endocarditis, Bacterial - microbiology | Streptococcus anginosus - drug effects | Streptococcus mitis - drug effects | Drug Resistance, Bacterial - drug effects | Drug Therapy, Combination | Endocarditis, Bacterial - drug therapy | Rabbits | Streptococcal Infections - microbiology | Streptococcus anginosus - physiology | Streptococcus mutans - drug effects | Endocarditis, Bacterial - complications | Streptococcus mitis - physiology | Drug Synergism | Daptomycin - pharmacology | Animals | Streptococcus bovis - drug effects | Streptococcal Infections - drug therapy | Anti-Bacterial Agents - pharmacology | Streptococcal Infections - complications | Index Medicus | Body weight | Experimental Therapeutics
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 11/2016, Volume 57, Issue 11, pp. 1726 - 1732
Infective endocarditis | Septic embolisms | Prosthetic valve | Implantable cardiac electronic devices | F-FDG-PET/CT | Endocarditis - etiology | Pacemaker, Artificial - adverse effects | Reproducibility of Results | Cross-Sectional Studies | Defibrillators, Implantable - adverse effects | Humans | Middle Aged | Male | Evidence-Based Medicine | Sensitivity and Specificity | Adult | Female | Fluorodeoxyglucose F18 | Aged | Endocarditis - diagnostic imaging | Image Enhancement - methods | Radiopharmaceuticals | Observer Variation | Positron Emission Tomography Computed Tomography - methods | Index Medicus | Pulmonary embolism | Case studies | Infeccions | Endocarditis | Embòlia pulmonar | Estudi de casos | Infections
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 12/2014, Volume 20, Issue 12, pp. O1075 - O1083
Enterococcus faecalis | infective endocarditis | outcomes | Ampicillin plus ceftriaxone | high-level aminoglycoside resistance | antimicrobial treatment | high‐level aminoglycoside resistance | Infective endocarditis | Antimicrobial treatment | High-level aminoglycoside resistance | Outcomes | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Enterococcus faecalis - drug effects | Prospective Studies | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Renal Insufficiency - epidemiology | Anti-Bacterial Agents - therapeutic use | Endocarditis - microbiology | Renal Insufficiency - chemically induced | Gram-Positive Bacterial Infections - microbiology | Aged, 80 and over | Female | Anti-Bacterial Agents - adverse effects | Ampicillin - therapeutic use | Gentamicins - adverse effects | Gentamicins - therapeutic use | Ampicillin - adverse effects | Treatment Outcome | Endocarditis - epidemiology | Withholding Treatment | Gram-Positive Bacterial Infections - epidemiology | Enterococcus faecalis - isolation & purification | Drug Therapy, Combination - methods | Ceftriaxone - therapeutic use | Ceftriaxone - adverse effects | Spain - epidemiology | Survival Analysis | Aged | Endocarditis - drug therapy | Gram-Positive Bacterial Infections - drug therapy | Cohort Studies | Aminoglycosides | Care and treatment | Ampicillin | Analysis | Antibiotics | Drug therapy | Mortality | Index Medicus
Journal Article
The Journal of infection, ISSN 0163-4453, 2015, Volume 70, Issue 6, pp. 565 - 576
Infectious Disease | Infective endocarditis | Literature review | Transcatheter aortic valve implantation | Outcome | TAVI | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Staphylococcal Infections - drug therapy | Prognosis | Prosthesis-Related Infections - complications | Staphylococcus epidermidis - isolation & purification | Humans | Risk Factors | Staphylococcal Infections - complications | Staphylococcal Infections - mortality | Endocarditis - mortality | Fatal Outcome | Aged, 80 and over | Female | Endocarditis - drug therapy | Anti-Bacterial Agents - administration & dosage | Endocarditis - complications | Prosthesis-Related Infections - mortality | Transcatheter Aortic Valve Replacement - adverse effects | Heart valve diseases | Care and treatment | Cross infection | Nosocomial infections | Patient outcomes | Endocarditis | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 11/2011, Volume 306, Issue 20, pp. 2239 - 2247
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Heart Failure - surgery | Echocardiography | Prospective Studies | Hospital Mortality | Humans | Middle Aged | Male | Mortality - trends | Cardiovascular Surgical Procedures - mortality | Heart Valves - surgery | Endocarditis - microbiology | Endocarditis - mortality | Female | Aged | Heart Failure - etiology | Endocarditis - complications | Cohort Studies | Endocarditis - surgery | Heart Failure - mortality | Surgical outcomes | Heart failure | Heart surgery | Patients | Mortality
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 03/2020, Volume 64, Issue 3
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biofilms - drug effects | Staphylococcus aureus - genetics | Staphylococcal Infections - genetics | Humans | Methicillin-Resistant Staphylococcus aureus - drug effects | Methicillin - pharmacology | Multiplex Polymerase Chain Reaction | Staphylococcus aureus - pathogenicity | Virulence Factors | Microbial Sensitivity Tests | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Virulence - genetics | Endocarditis, Bacterial - prevention & control | Vancomycin - pharmacology | Endocarditis, Bacterial - genetics | Endocarditis, Bacterial - microbiology | Staphylococcal Infections - prevention & control | Anti-Bacterial Agents - pharmacology | Staphylococcal Infections - microbiology | Staphylococcus aureus - drug effects | Index Medicus
Journal Article